» Articles » PMID: 19364399

Cost Estimates of HIV Care and Treatment with and Without Anti-retroviral Therapy at Arba Minch Hospital in Southern Ethiopia

Overview
Publisher Biomed Central
Date 2009 Apr 15
PMID 19364399
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Little is known about the costs of HIV care in Ethiopia.

Objective: To estimate the average per person year (PPY) cost of care for HIV patients with and without anti-retroviral therapy (ART) in a district hospital.

Methods: Data on costs and utilization of HIV-related services were taken from Arba Minch Hospital (AMH) in southern Ethiopia. Mean annual outpatient and inpatient costs and corresponding 95% confidence intervals (CI) were calculated. We adopted a district hospital perspective and focused on hospital costs.

Findings: PPY average (95% CI) costs under ART were US$235.44 (US$218.11-252.78) and US$29.44 (US$24.30-34.58) for outpatient and inpatient care, respectively. Estimates for the non-ART condition were US$38.12 (US$34.36-41.88) and US$80.88 (US$63.66-98.11) for outpatient and inpatient care, respectively. The major cost driver under the ART scheme was cost of ART drugs, whereas it was inpatient care and treatment in the non-ART scheme.

Conclusion: The cost profile of ART at a district hospital level may be useful in the planning and budgeting of implementing ART programs in Ethiopia. Further studies that focus on patient costs are warranted to capture all patterns of service use and relevant costs. Economic evaluations combining cost estimates with clinical outcomes would be useful for ranking of ART services.

Citing Articles

Impact of the COVID-19 pandemic on the cost of chronic diseases treatment and care at public hospitals in Wallaga zones, Oromia Regional State, Ethiopia: a hospital-based, cross-sectional study.

Terefa D, Tesfaye E, Tolessa B, Desisa A, Olani W, Fetensa G BMJ Open. 2023; 13(11):e070195.

PMID: 37931966 PMC: 10632867. DOI: 10.1136/bmjopen-2022-070195.


Management of diabetes and associated costs in a complex humanitarian setting in the Democratic Republic of Congo: a retrospective cohort study.

Ansbro E, Biringanine M, Caleo G, Prieto-Merino D, Sadique Z, Perel P BMJ Open. 2019; 9(11):e030176.

PMID: 31767582 PMC: 6887084. DOI: 10.1136/bmjopen-2019-030176.


Assessing the cost of providing a prevention of mother-to-child transmission of HIV/AIDS service in Ethiopia: urban-rural health facilities setting.

Zegeye E, Mbonigaba J, Kaye S, Johns B BMC Health Serv Res. 2019; 19(1):148.

PMID: 30841870 PMC: 6404341. DOI: 10.1186/s12913-019-3978-4.


Costs incurred by outpatients at a university hospital in northwestern Ethiopia: a cross-sectional study.

Teni F, Gebresillassie B, Birru E, Belachew S, Tefera Y, Wubishet B BMC Health Serv Res. 2018; 18(1):842.

PMID: 30409194 PMC: 6225699. DOI: 10.1186/s12913-018-3628-2.


Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics.

Bautista-Arredondo S, Colchero M, Amanze O, La Hera-Fuentes G, Silverman-Retana O, Contreras-Loya D PLoS One. 2018; 13(5):e0194305.

PMID: 29718906 PMC: 5931468. DOI: 10.1371/journal.pone.0194305.


References
1.
Jerene D, Naess A, Lindtjorn B . Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res Ther. 2006; 3:10. PMC: 1475602. DOI: 10.1186/1742-6405-3-10. View

2.
Badri M, Maartens G, Mandalia S, Bekker L, Penrod J, Platt R . Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med. 2005; 3(1):e4. PMC: 1298940. DOI: 10.1371/journal.pmed.0030004. View

3.
Bertozzi S, Gutierrez J, Opuni M, Walker N, Schwartlander B . Estimating resource needs for HIV/AIDS health care services in low-income and middle-income countries. Health Policy. 2004; 69(2):189-200. DOI: 10.1016/j.healthpol.2003.12.010. View

4.
Jerene D, Lindtjorn B . Disease progression among untreated HIV-infected patients in South Ethiopia: implications for patient care. MedGenMed. 2005; 7(3):66. PMC: 1681623. View

5.
Cleary S, McIntyre D, Boulle A . The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis. Cost Eff Resour Alloc. 2006; 4:20. PMC: 1770938. DOI: 10.1186/1478-7547-4-20. View